Related Experiment Video
Updated: Oct 31, 2025

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
Published on: April 22, 2015
Melatonin Treatment and Adequate Sleep Hygiene Interventions in Children with Autism Spectrum Disorder: A Randomized
Masaharu Hayashi1, Kazuo Mishima2, Michio Fukumizu3
1School of Nursing, College of Nursing and Nutrition, Shukutoku University, 673, Nitona-cho, Chuo-ku, Chiba, 260-8703, Japan. Masaharu.hayashi@soc.shukutoku.ac.jp.
Insights
Melatonin effectively treats sleep problems in children with autism spectrum disorder (ASD). This study found that melatonin significantly reduced sleep onset latency in children with ASD compared to placebo.
Area of Science:
- Pediatric Neurology
- Sleep Medicine
- Autism Spectrum Disorder Research
Background:
- Melatonin is frequently used for sleep issues in children with autism spectrum disorder (ASD), but robust clinical evidence was lacking.
- Sleep disturbances are common in children with ASD, impacting their quality of life and development.
Purpose of the Study:
- To evaluate the efficacy of melatonin in treating sleep onset latency (SOL) in children with ASD.
- To provide robust clinical evidence for melatonin use in this population.
Main Methods:
- A phase 3, randomized, placebo-controlled clinical trial involving 196 children with ASD.
- Participants received 1-mg melatonin, 4-mg melatonin, or placebo daily before bedtime, alongside sleep hygiene interventions.
- Sleep onset latency was measured using electronic sleep diaries.
Main Results:
- Both 1-mg and 4-mg melatonin doses significantly shortened sleep onset latency compared to placebo.
- The mean SOL reduction was -22.0 minutes for 1-mg melatonin and -28.0 minutes for 4-mg melatonin (p < 0.0001).
- Placebo group showed a mean SOL reduction of -5.0 minutes.
Conclusions:
- Melatonin is a clinically reasonable and effective treatment for sleep onset difficulties in children with ASD.
- This study provides strong evidence supporting the use of melatonin for managing sleep problems in pediatric ASD.
- The findings support the integration of melatonin into clinical practice for children with ASD experiencing sleep disturbances.
Abstract:
Robust clinical evidence has not been available for melatonin, a drug commonly administered for treating sleep problems of children with autism spectrum disorder (ASD). In a phase 3 randomized, placebo-controlled clinical trial, we administered 1-mg melatonin (n = 65), 4-mg melatonin (n = 65), or placebo (n = 66) to196 children with ASD once daily before bedtime under adequate sleep hygiene interventions. The primary outcome was sleep onset latency (SOL) assessed with the electronic sleep diary. SOL shortened significantly in the 1- and 4-mg melatonin groups compared to the placebo group (- 22.0, - 28.0, and - 5.0 min, respectively; p < 0.0001 each). This therapeutic regimen of melatonin is a reasonable clinical approach to cope with ASD-emergent difficulties in children with ASD.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Management of Insomnia
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Insomnia
Multiple factors contribute...
Nightmares and Night Terrors
Nightmares...
REM Sleep Behavior Disorder
RBD is significantly associated with...

